Introducing SJC Bio
Vanderbilt Professor of
Chemical, Biomolecular, and
Biomedical Engineering
SJC Bio is a new venture formed to commercialize breakthrough technology from the laboratory of Dr. Scott Guelcher, Vanderbilt Professor of Chemical, Biomolecular, and Biomedical Engineering. comprising biodegradable bone grafts for dental applications. The company was founded by an experienced entrepreneur and is seeking capital to fund further development of the polymer technology.
This development work will include sponsored pre-clinical research in Dr. Guelcher's lab to support an Investigational Device Exemption (IDE) submission to the FDA. Since the early 2000's, Dr. Guelcher's lab has been developing a series of biodegradable structural polymers for medical uses, targeting bone grafts as the primary application. Much of his early research was supported through a combination of federal grants and industry contracts, leading to several inventions that were licensed to a large medical device company. His team has now developed related but novel polymer formulations that are well suited for dental applications, including adhesives and bone grafts for augmenting or reconstructing periodontal or bony defects of the oral or maxillofacial region. Specifically, these new formulations possess a combination of adhesive strength, cohesive strength, and degradation properties that can enable same-day dental implant procedures that typically require multiple dental appointments over the course of several months.